FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/12/022259 [Registered on: 05/12/2019] Trial Registered Prospectively
Last Modified On: 30/11/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical trial to study the effect of kushmanand beej churn and satvavajaya chikitsa in the patient having sign and symptoms of dhee dhriti and smriti ( manas rog)  
Scientific Title of Study   “An Etiopathological Study of impairment of Dhee Dhriti Smriti w.s.r. to Mild Cognitive Impairment and Therapeutic Evaluation of Kushmanda Beeja Churna and Satvavajaya Chikitsa”  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anshu Sharma 
Designation  M.D. scholar 
Affiliation  National Institute of Ayurveda 
Address  P.G. Department of Roga Evam Vikriti Vigyan,National Institute of Ayurveda, jorawar singh gate madhav vilas palace , jaipur
P.G. Department of Roga Evam Vikriti Vigyan,National Institute of Ayurveda, jorawar singh gate madhav vilas palace ,jaipur
Jaipur
RAJASTHAN
302002
India 
Phone  8890233668  
Fax    
Email  anshusharma6668@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  professor surendra kumar sharma 
Designation  professor 
Affiliation  National Institute of Ayurveda 
Address  P.G. Department of Roga Evam Vikriti Vigyan,National Institute of Ayurveda, jorawar singh gate madhav vilas palace , jaipur
P.G. Department of Roga Evam Vikriti Vigyan,National Institute of Ayurveda, jorawar singh gate madhav vilas palace , jaipur
Jaipur
RAJASTHAN
302002
India 
Phone  9414361874  
Fax    
Email  drsksm31@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Anshu Sharma 
Designation  M.D. scholar 
Affiliation  National Institute of Ayurveda 
Address  P.G. Department of Roga Evam Vikriti Vigyan,,National Institute of Ayurveda, jorawar singh gate madhav vilas palace , jaipu
P.G. Department of Roga Evam Vikriti Vigyan,,National Institute of Ayurveda, jorawar singh gate madhav vilas palace , jaipu
Jaipur
RAJASTHAN
302002
India 
Phone  08890233668  
Fax    
Email  anshusharma6668@gmail.com  
 
Source of Monetary or Material Support  
national institute of ayurveda jaipur 
 
Primary Sponsor  
Name  NATIOINAL INSTITUTE OF AYURVEDA JAIPUR 
Address  NATIOINAL INSTITUTE OF AYURVEDA JORAWAR SINGH GATE AMER ROAD JAIPUR 302002 rajasthan 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
ANSHU SHARMA  NATIOINAL INSTITUTE OF AYURVEDA HOSPITAL JAIPUR  NATIONAL INSTITUTE OF AYURVEDA HOSPITAL AMER ROAD JAIPUR
Jaipur
RAJASTHAN 
8890233668

anshusharma6668@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional Ethics committee national institute of ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F19||Other psychoactive substance related disorders,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  kushmand beej churn   6 gm BD with honey after meal 
Comparator Agent  kushmand beej churn and satvavajaya chikitsa  6 gm BD as well as with honey and satvavajaya chikitsa 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  The Individuals having the all age group more than 18 years with impairment of Dhee, Dhriti and Smriti. 
 
ExclusionCriteria 
Details  Schizophrenia, Parkinsonism, Dementia, Alzheimer, Uremia, Encephalopathy preganant women, lactating mother and any major systemic disorder.  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
patients of both sexes age group above 18 years of dhee dhriti smriti will be selected for reliving sign and symptoms  patients of both sexes age group above 18 years of dhee dhriti smriti will be selected for reliving sign and symptoms 
 
Secondary Outcome  
Outcome  TimePoints 
asses the comparative efficacy between both groups after 8 weeks in case of dhee dhriti and smriti impairment.  asses the comparative efficacy between both groups after 8 weeks in case of dhee dhriti and smriti impairment 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   05/12/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Not Published Yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This is open label randomised single centre comparing efficacy of ayurvedic drug kushmand beej and kushmand beej ,satvavajaya chikitsa  in the management of dhee, dhriti, smriti (mild coginitive impairment). Patients of both sexes age of 18 years and above of dhee dhriti smriti  will be selected for relieving sign and symptoms. 60 clinically diagnoded and confirmed patients will be divided into two groups for administration of trial drug. In group A  30 patients will be administered trial drug kushmand beej in the dose of 6 gm BD orally for 60 days . In group B  30 patients will be administered trial drug kushmand beej as well as witrh satvavajaya chikitsa for 60 days . All the patients registered for clinical trial will be asked for any changes in their clinical manifestation and growing feeling of well being. conclusion - To compare the efficacy of both the groups. 
Close